Cite
HARVARD Citation
Patel, A. et al. (2021). Contemporary use of guideline‐based higher potency P2Y12 receptor inhibitor therapy in patients with moderate‐to‐high risk non‐ST‐segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross‐sectional study. Clinical cardiology. 44 (6), pp. 839-847. [Online].